PSMA targeted fluorescent agents for image guided surgery

US11021450B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11021450-B2
Application numberUS-202016820052-A
CountryUS
Kind codeB2
Filing dateMar 16, 2020
Priority dateMar 19, 2009
Publication dateJun 1, 2021
Grant dateJun 1, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods for visualizing tissue under illumination with near-infrared radiation, including compounds comprising near-infrared, closed chain, sulfo-cyanine dyes and prostate specific membrane antigen ligands are disclosed.

First claim

Opening claim text (preview).

That which is claimed: 1. A compound having the structure: wherein: Z is tetrazole or CO 2 Q; each Q is independently selected from hydrogen or a protecting group; FG is a fluorescent dye moiety which emits in the visible or near infrared spectrum; each R is independently H or C 1 -C 4 alkyl; V is —C(O)—; W is —NRC(O); Y is —C(O); a is 1, 2, 3, or 4; m is 1, 2, 3, 4, 5, or 6; n is 1, 2, 3, 4, 5 or 6; p is 0, 1, 2, or 3, and when p is 2 or 3, each R 1 may be the same or different; R 1 is H, C 1 -C 6 alkyl, C 6 -C 12 aryl, or alkylaryl having 1 to 3 separate or fused rings and from 6 to about 18 ring carbon atoms; R 2 and R 3 are independently H, CO 2 H, or CO 2 R 4 , where R 4 is a C 1 -C 6 alkyl, C 6 -C 12 aryl, or alkylaryl having 1 to 3 separate or fused rings and from 6 to about 18 ring carbon atoms, wherein when one of R 2 and R 3 is CO 2 H or CO 2 R 4 , the other is H. 2. A compound according to claim 1 having the structure: 3. A compound according to claim 2 having the structure: 4. A compound according to claim 1 , wherein R 3 is CO 2 H and R 2 is H or R 2 is CO 2 H and R 3 is H. 5. A compound according to claim 1 , wherein R 2 is CO 2 R 4 and R 3 is H or R 3 is CO 2 R 4 , and R 2 is H. 6. A compound according to claim 1 , wherein R 2 is H, and R 3 is H. 7. A compound according to claim 1 , wherein R 4 is C 6 -C 12 aryl, or alkylaryl having 1 to 3 separate or fused rings and from 6 to about 18 ring carbon atoms. 8. A compound according to claim 1 , wherein R 1 is C 6 -C 12 aryl. 9. A compound according to claim 8 wherein R 1 is phenyl. 10. A compound according to claim 1 , wherein FG is a fluorescent dye moiety which emits in the near infrared spectrum. 11. A compound according to claim 1 , wherein FG is selected from the group consisting of a polymethine dye, a coumarin dye, a xanthene dye, and a boron-dipyrromethene dye. 12. A compound according to claim 1 , wherein FG has a structure selected from the group consisting of: 13. A compound according to claim 1 selected from the group consisting of: 14. A method of imaging one or more cells, organs or tissues by exposing the cell to or administering to an organism an effective amount of a compound according to claim 1 , where the compound includes a fluorescent dye moiety suitable for imaging. 15. A method for sorting cells by exposing the cells to a compound according to claim 1 , where the compound includes a fluorescent dye moiety, followed by separating cells which bind the compound from cells which do not bind the compound. 16. A method for intraoperative tumor mapping comprising administering an effective amount of a compound according to claim 1 , where the compound includes a fluorescent dye moiety. 17. A kit comprising a compound according to claim 1 . 18. The compound according to claim 1 , wherein the protecting group is selected from the group consisting of benzyl, p-methoxybenzyl, tertiary butyl, methoxymethyl, methoxyethoxymethyl, methylthiomethyl, tetrahydropyranyl, tetrahydrofuranyl, benzyloxymethyl, trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, and triphenylmethyl. 19. The compound according to claim 11 , wherein the polymethine dye is selected from the group consisting of a carbocyanine dye, a indocarbocyanine dye, an oxacarbocyanine dye, a thiacarbocyanine dye, and a merocyanine dye. 20. The compound according to claim 19 , wherein the polymethine dye comprises an indocarbocyanine. 21. The compound according to claim 11 , wherein the xanthene dye is selected from the group consisting of a fluorescein dye and a coumarin dye.

Assignees

Inventors

Classifications

  • Radicals substituted by oxygen atoms · CPC title

  • with an alkyl or cycloalkyl radical attached to the ring nitrogen atom · CPC title

  • Methine dyes, e.g. cyanine dyes · CPC title

  • Xanthenes · CPC title

  • having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11021450B2 cover?
Compositions and methods for visualizing tissue under illumination with near-infrared radiation, including compounds comprising near-infrared, closed chain, sulfo-cyanine dyes and prostate specific membrane antigen ligands are disclosed.
Who is the assignee on this patent?
Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification C07D257/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).